COVID public health emergency is over: Here's what it means for you

The government officially ended the COVID-19 Public Health Emergency (PHE) on May 11. Now that the public health emergency is officially over, how will things change?

More News

Nearly 5M Target candles recalled due to consumer injury reports

About 4.9 million Target candles were recalled on Thursday, after six people reported injuries, according to the U.S. Consumer Product Safety Commission (CPSC). The Threshold candles, which

How the end of the COVID-19 public health emergency is impacting people

The Groton nursing and independent living facility Fairview posted a video a week and a half ago in which nurses removed their masks in unison, threw them into the air graduation-ceremony style, and shouted,

Ocaliva for NASH Gets Thumbs Down From FDA Advisors

On Friday, the Gastrointestinal Drugs Advisory Committee voted 12-2 (with two abstentions) that the improvements in liver scarring seen in the pivotal REGENERATE trial with a 25-mg dose of obeticholic acid do not outweigh the various risks,

Contaminated eyedrops now linked to 4 deaths, 14 cases of blindness: CDC

Eye drops that have been contaminated with a highly drug-resistant strain of bacteria have now been linked to four deaths and 14 cases of blindness, according to an update from the Centers for

'Staggering' Weight Loss and Benefits in Body Composition With Tirzepatide

Over 60% of participants achieved the weight-reduction target of 20% or higher and had improved body composition in a phase 3 trial of tirzepatide in overweight/obesity.

Maine officials confirm first Powassan virus death of 2023

Officials in Maine have confirmed the first fatal case of the Powassan virus disease in 2023. The Maine Center for Disease Control said Wednesday they found the tick-borne illness in an adult resident from Sagadahoc County.

Rare Skin Blistering Condition Gets First Drug Approved

The FDA granted the first drug approval for dystrophic epidermolysis bullosa (DEB), a topical gene therapy that treats the blistering wounds it causes, the agency announced Friday. The herpes-simplex virus type 1 vector-based gene therapy,

.

.